|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4361549A
(en)
|
1979-04-26 |
1982-11-30 |
Ortho Pharmaceutical Corporation |
Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
|
|
US4537776A
(en)
|
1983-06-21 |
1985-08-27 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
ES2073394T3
(es)
|
1987-06-10 |
1995-08-16 |
Dana Farber Cancer Inst Inc |
Constructos de anticuerpos bifuncionales y su utilizacion para destruir selectivamente las poblaciones celulares.
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
DK0489116T3
(da)
|
1989-08-22 |
1994-05-02 |
Immunex Corp |
Fusionsproteiner omfattende GM-CSF og IL-3
|
|
JP2546544B2
(ja)
|
1989-10-27 |
1996-10-23 |
アーチ ディベラップメント コーポレイション |
免疫強化を促進するための方法と組成物
|
|
US6406696B1
(en)
|
1989-10-27 |
2002-06-18 |
Tolerance Therapeutics, Inc. |
Methods of stimulating the immune system with anti-CD3 antibodies
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US6750325B1
(en)
|
1989-12-21 |
2004-06-15 |
Celltech R&D Limited |
CD3 specific recombinant antibody
|
|
CA2084987C
(en)
|
1990-06-11 |
2007-02-13 |
Gilead Sciences, Inc. |
Nucleic acid ligands
|
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
SE9201966D0
(sv)
|
1992-06-25 |
1992-06-25 |
Trion Forskning & Utveckling |
Interleukin-1beta deletion mutant
|
|
EP1498427B1
(en)
|
1992-08-21 |
2009-12-16 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US6491916B1
(en)
|
1994-06-01 |
2002-12-10 |
Tolerance Therapeutics, Inc. |
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
|
|
US5914254A
(en)
|
1993-08-02 |
1999-06-22 |
Celtrix Pharmaceuticals, Inc. |
Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
|
|
US5595756A
(en)
*
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
SE9400088D0
(sv)
|
1994-01-14 |
1994-01-14 |
Kabi Pharmacia Ab |
Bacterial receptor structures
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
EP0773952B1
(en)
|
1994-07-20 |
2003-11-12 |
The General Hospital Corporation |
Interaction trap systems for detecting protein interactions
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
AU6961796A
(en)
|
1995-09-12 |
1997-04-01 |
Chiron Corporation |
Improved interleukin-6 receptor antagonist
|
|
ES2219679T3
(es)
|
1995-10-18 |
2004-12-01 |
Akzo Nobel N.V. |
Vacuna de combinacion contra la enfermedad de newcastle.
|
|
US5716946A
(en)
|
1996-02-13 |
1998-02-10 |
Wisconsin Alumni Research Foundation |
Multiple sclerosis treatment
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US5986059A
(en)
|
1996-06-14 |
1999-11-16 |
Bayer Corporation |
T-cell selective interleukin-4 agonists
|
|
US6653104B2
(en)
|
1996-10-17 |
2003-11-25 |
Immunomedics, Inc. |
Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
|
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
|
BR9907241A
(pt)
|
1998-01-26 |
2000-10-17 |
Unilever Nv |
Biblioteca de expressão, processo para preparar a mesma, uso de uma fonte não imunizada de sequências de ácido nucleico, e, processos para preparar fragmentos de anticorpos e, para preparar um anticorpo
|
|
AUPP221098A0
(en)
|
1998-03-06 |
1998-04-02 |
Diatech Pty Ltd |
V-like domain binding molecules
|
|
WO2002018422A1
(en)
|
2000-08-30 |
2002-03-07 |
The Penn State Research Foundation |
Amino acid substitution mutants of interleukin 13
|
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
WO2000043507A1
(en)
|
1999-01-19 |
2000-07-27 |
Unilever Plc |
Method for producing antibody fragments
|
|
ATE320486T1
(de)
|
1999-05-05 |
2006-04-15 |
Phylogica Ltd |
Isolierung von biologischen modulatoren aus bibiotheken mit biologisch vielfältigen genfragmenten
|
|
AU4761100A
(en)
|
1999-05-26 |
2000-12-18 |
Kalle Saksela |
Methods and materials for generating sh3 domains with tailored binding properties
|
|
JP2001026545A
(ja)
|
1999-07-09 |
2001-01-30 |
Takara Shuzo Co Ltd |
免疫応答活性化製剤
|
|
CA2383424C
(en)
|
1999-08-23 |
2011-02-15 |
Gordon Freeman |
Novel b7-4 molecules and uses therefor
|
|
US7101974B2
(en)
|
2000-03-02 |
2006-09-05 |
Xencor |
TNF-αvariants
|
|
US6613756B2
(en)
|
2000-05-05 |
2003-09-02 |
Wisconsin Alumni Research Foundation |
Use of tetracycline derivatives in treating multiple sclerosis
|
|
SE0001877D0
(sv)
|
2000-05-22 |
2000-05-22 |
Klaus Mosbach |
Molecular imprinting
|
|
CA2380443C
(en)
|
2000-05-26 |
2013-03-12 |
Ginette Dubuc |
Single-domain antigen-binding antibody fragments derived from llama antibodies
|
|
GB0014356D0
(en)
|
2000-06-12 |
2000-08-02 |
Colover Jack |
Treatment of multiple sclerosis
|
|
US20020025304A1
(en)
|
2000-06-16 |
2002-02-28 |
Croze Edward M. |
Novel interferon for the treatment of multiple sclerosis
|
|
CA2421447C
(en)
|
2000-09-08 |
2012-05-08 |
Universitat Zurich |
Collections of repeat proteins comprising repeat modules
|
|
DE10053224A1
(de)
|
2000-10-26 |
2002-05-08 |
Univ Goettingen Georg August |
Verfahren zur Exposition von Peptiden und Polypeptiden auf der Zelloberfläche von Bakterien
|
|
US20040132094A1
(en)
|
2000-12-13 |
2004-07-08 |
Michael Etzerodt |
Combinatorial libraries of proteins having the scaffold structure of c-type lectinlike domains
|
|
GB0110029D0
(en)
|
2001-04-24 |
2001-06-13 |
Grosveld Frank |
Transgenic animal
|
|
JP2005508623A
(ja)
|
2001-08-30 |
2005-04-07 |
バイオレクシス ファーマシューティカル コーポレイション |
改変されたトランスフェリン融合タンパク質
|
|
EP1433793A4
(en)
|
2001-09-13 |
2006-01-25 |
Inst Antibodies Co Ltd |
METHOD FOR CREATING A CAMEL ANTIBODY LIBRARY
|
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
IL149820A0
(en)
|
2002-05-23 |
2002-11-10 |
Curetech Ltd |
Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
|
|
EP2206517B1
(en)
|
2002-07-03 |
2023-08-02 |
Ono Pharmaceutical Co., Ltd. |
Immunopotentiating compositions comprising anti-PD-L1 antibodies
|
|
ZA200502867B
(en)
|
2002-10-02 |
2007-09-26 |
Catalyst Biosciences Inc |
Methods of generating and screening for proteases with altered specificity
|
|
WO2004041862A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
GB0228210D0
(en)
|
2002-12-03 |
2003-01-08 |
Babraham Inst |
Single chain antibodies
|
|
EP1567192A4
(en)
|
2002-12-05 |
2006-02-08 |
Protein Design Labs Inc |
TECHNIQUES FOR TREATING ULCERO-HEMORRHAGIC RECTO-COLITIS WITH ANTI-CD3 ANTIBODIES
|
|
CN1753912B
(zh)
|
2002-12-23 |
2011-11-02 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
DE60329627D1
(de)
|
2002-12-31 |
2009-11-19 |
Nektar Therapeutics Al Corp |
Hydrolysestabile maleimidendgruppen-enthaltende polymere
|
|
WO2004063337A2
(en)
|
2003-01-07 |
2004-07-29 |
Dyax Corporation |
Kunitz domain library
|
|
CA2523716C
(en)
|
2003-05-31 |
2014-11-25 |
Micromet Ag |
Human anti-human cd3 binding molecules
|
|
TW200526780A
(en)
|
2004-01-06 |
2005-08-16 |
Hayashibara Biochem Lab |
TNF antagonists and TNF inhibitors comprising the same as the active ingredient
|
|
US20110020273A1
(en)
*
|
2005-04-06 |
2011-01-27 |
Ibc Pharmaceuticals, Inc. |
Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof
|
|
US7318918B2
(en)
*
|
2004-05-19 |
2008-01-15 |
Maxygen, Inc. |
Interferon-alpha polypeptides and conjugates
|
|
CA2569509C
(en)
|
2004-06-03 |
2014-08-12 |
Novimmune S.A. |
Anti-cd3 antibodies and methods of use thereof
|
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
|
CN100523739C
(zh)
|
2004-07-12 |
2009-08-05 |
三菱电机株式会社 |
光学式编码器
|
|
DE102004049479A1
(de)
|
2004-10-11 |
2006-04-13 |
Scil Proteins Gmbh |
Proteinkonjugate zur Verwendung in Therapie, Diagnose und Chromatographie
|
|
US7575878B2
(en)
|
2004-11-18 |
2009-08-18 |
Vib Vzw |
Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies
|
|
WO2006055871A2
(en)
|
2004-11-19 |
2006-05-26 |
Biogen Idec Ma Inc. |
Treatment for multiple sclerosis
|
|
WO2006115800A2
(en)
|
2005-04-15 |
2006-11-02 |
The Regents Of The University Of California |
Enhanced wound healing utilizing an anti-her2 antibody coupled to a tnf alpha
|
|
ES2720160T3
(es)
|
2005-05-09 |
2019-07-18 |
Ono Pharmaceutical Co |
Anticuerpos monoclonales humanos contra muerte programada 1(PD-1) y métodos para tratar el cáncer usando anticuerpos dirigidos contra PD-1 solos o junto con otras sustancias inmunoterapéuticas
|
|
RU2464276C2
(ru)
|
2005-05-18 |
2012-10-20 |
Аблинкс Н.В. |
Улучшенные нанотела против фактора некроза опухоли-альфа
|
|
CN104436190A
(zh)
*
|
2005-06-08 |
2015-03-25 |
达纳-法伯癌症研究院公司 |
通过抑制程序性细胞死亡1(pd-1)途经治疗持续性感染和癌症的方法及组合物
|
|
GB0513047D0
(en)
|
2005-06-27 |
2005-08-03 |
Thermo Finnigan Llc |
Electronic ion trap
|
|
EA019344B1
(ru)
|
2005-07-01 |
2014-03-31 |
МЕДАРЕКС, Эл.Эл.Си. |
Человеческие моноклональные антитела против лиганда-1 запрограммированной гибели клеток (pd-l1) и их применения
|
|
TW200732347A
(en)
|
2005-10-06 |
2007-09-01 |
Trophogen Inc |
VEGF analogs and methods of use
|
|
US7947265B2
(en)
|
2006-08-02 |
2011-05-24 |
Mcgill University |
Fusion proteins and methods for modulation of immune response
|
|
EP1892248A1
(en)
|
2006-08-21 |
2008-02-27 |
Eidgenössische Technische Hochschule Zürich |
Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase
|
|
US8907065B2
(en)
|
2006-12-15 |
2014-12-09 |
Ablynx N.V. |
Polypeptides that modulate the interaction between cells of the immune system
|
|
US9023352B2
(en)
|
2007-02-20 |
2015-05-05 |
Tufts University |
Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
|
|
US11535673B2
(en)
|
2007-04-05 |
2022-12-27 |
President and Fellows of Harvard CoHege |
Chimeric activators: quantitatively designed protein therapeutics and uses thereof
|
|
MX367012B
(es)
|
2007-06-01 |
2019-08-02 |
Univ Maryland |
Agentes de union al receptor de la region constante fc de inmunoglobulina.
|
|
JP5191537B2
(ja)
|
2007-06-18 |
2013-05-08 |
エム・エス・ディー・オス・ベー・フェー |
ヒトのプログラムされたデスレセプターｐｄ−１に対する抗体
|
|
US20110038865A1
(en)
|
2007-06-26 |
2011-02-17 |
University Of Miami |
Antibody- endostatin fusion protein and its variants
|
|
GB0805159D0
(en)
*
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
|
CN101868246A
(zh)
|
2007-09-21 |
2010-10-20 |
加利福尼亚大学董事会 |
被导靶的干扰素显示强的细胞凋亡和抗肿瘤活性
|
|
HUE026591T2
(hu)
|
2007-11-29 |
2016-06-28 |
Molecular Health Gmbh |
Szövetvédõ eritropoietin receptor (nepor) és alkalmazási eljárásai
|
|
US20100285039A1
(en)
|
2008-01-03 |
2010-11-11 |
The Johns Hopkins University |
B7-H1 (CD274) Antagonists Induce Apoptosis of Tumor Cells
|
|
EP2242773B1
(en)
|
2008-02-11 |
2017-06-14 |
Cure Tech Ltd. |
Monoclonal antibodies for tumor treatment
|
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
|
EP2328920A2
(en)
|
2008-08-25 |
2011-06-08 |
Amplimmune, Inc. |
Targeted costimulatory polypeptides and methods of use to treat cancer
|
|
RS54233B1
(sr)
|
2008-08-25 |
2015-12-31 |
Amplimmune Inc. |
Kompozicije pd-1 antagonista i postupci za njihovu primenu
|
|
US20110224407A1
(en)
|
2008-09-09 |
2011-09-15 |
University Of Medicine And Dentistry Of New Jersey |
Type I Interferon Antagonists
|
|
US8334101B2
(en)
|
2008-09-26 |
2012-12-18 |
University Of Massachusetts |
Intracellular DNA receptor
|
|
BRPI0919377A2
(pt)
|
2008-09-26 |
2016-09-27 |
Dana Farber Cancer Inst Inc |
anticorpo isolado ou um fragmento ligante de antígeno do memso, ácido nucleico isolado, vetor, célula hospedeira, composição farmacêutica, método de produzir o referido anticorpo ou fragmento, uso dos mesmos, e composição compreendendo o referido anticorpo ou fragmento
|
|
DK2367840T3
(en)
|
2008-12-08 |
2015-10-12 |
Complix N V |
SINGLE CHAIN antiparallel coiled-coil PROTEINS
|
|
HUE065752T2
(hu)
|
2008-12-09 |
2024-06-28 |
Hoffmann La Roche |
Anti-PD-L1 antitestek és felhasználásuk T-sejt funkció elõsegítésére
|
|
ES2629337T3
(es)
|
2009-02-09 |
2017-08-08 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Anticuerpos contra PD-1 y anticuerpos contra PD-L1 y usos de los mismos
|
|
AU2010228108A1
(en)
*
|
2009-03-23 |
2011-11-03 |
The Walter And Eliza Hall Institute Of Medical Research |
Compounds and methods for modulating an immune response
|
|
MX2012002014A
(es)
|
2009-08-17 |
2012-06-13 |
Roche Glycart Ag |
Inmunoconjugados dirigidos.
|
|
WO2011025904A1
(en)
|
2009-08-31 |
2011-03-03 |
Ibc Pharmaceuticals, Inc. |
Bispecific immunocytokine dock-and-lock (dnl) complexes and therapeutic use thereof
|
|
CN102497885A
(zh)
|
2009-09-10 |
2012-06-13 |
赛托斯生物技术公司 |
白介素-1β突变蛋白偶联物在糖尿病治疗中的用途
|
|
PT2504364T
(pt)
|
2009-11-24 |
2017-11-14 |
Medimmune Ltd |
Agentes de ligação direcionados contra b7-h1
|
|
EP2504028A4
(en)
|
2009-11-24 |
2014-04-09 |
Amplimmune Inc |
SIMULTANEOUS INHIBITION OF PD-L1 / PD-L2
|
|
US20110262348A1
(en)
|
2010-03-29 |
2011-10-27 |
Vrije Universiteit Brussel |
Selective targeting of intratumoral cells
|
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
|
RU2577299C2
(ru)
|
2011-07-04 |
2016-03-10 |
Олег Ильич Эпштейн |
Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний
|
|
US9266938B2
(en)
|
2011-02-10 |
2016-02-23 |
Roche Glycart Ag |
Mutant interleukin-2 polypeptides
|
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン，エルエルシー |
Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子
|
|
WO2012170072A1
(en)
|
2011-06-06 |
2012-12-13 |
Immungene, Inc. |
Engineered antibody-tnfsf member ligand fusion molecules
|
|
SE535863C2
(sv)
|
2011-07-18 |
2013-01-22 |
Atlas Copco Ind Tech Ab |
Hållare för motordrivet verktyg innefattande klämdelar med genomgående hål
|
|
WO2013053008A2
(en)
|
2011-10-14 |
2013-04-18 |
The Walter And Eliza Hall Institute Of Medical Research |
Molecules which bind clec9a
|
|
EP3559049B1
(en)
*
|
2011-10-28 |
2025-06-11 |
Teva Pharmaceuticals Australia Pty Ltd |
Polypeptide constructs and uses thereof
|
|
EP2804877B1
(en)
|
2012-01-20 |
2018-08-22 |
VIB vzw |
Targeted mutant alpha-helical bundle cytokines
|
|
IN2014DN08236A
(enExample)
|
2012-03-03 |
2015-05-15 |
Immungene Inc |
|
|
WO2013163689A1
(en)
|
2012-05-01 |
2013-11-07 |
The University Of Sydney |
Vaccine and uses thereof
|
|
US9212224B2
(en)
|
2012-05-15 |
2015-12-15 |
Bristol-Myers Squibb Company |
Antibodies that bind PD-L1 and uses thereof
|
|
WO2013186613A1
(en)
|
2012-06-14 |
2013-12-19 |
Nasvax Ltd. |
Humanized antibodies to cluster of differentiation 3 (cd3)
|
|
WO2013188693A1
(en)
|
2012-06-15 |
2013-12-19 |
Imaginab, Inc. |
Antigen binding constructs to cd3
|
|
US20150191543A1
(en)
*
|
2012-08-06 |
2015-07-09 |
The Regents Of The University Of California |
Engineered antibody fragments for targeting and imaging cd8 expression in vivo
|
|
WO2014028502A1
(en)
*
|
2012-08-13 |
2014-02-20 |
ImmunGene Inc. |
Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases
|
|
CN102775502A
(zh)
*
|
2012-08-16 |
2012-11-14 |
天津禹王生物医药科技有限公司 |
α干扰素融合蛋白
|
|
AU2014249243C1
(en)
|
2013-03-13 |
2019-08-08 |
Imaginab, Inc. |
Antigen binding constructs to CD8
|
|
TW201501724A
(zh)
|
2013-03-15 |
2015-01-16 |
Glaxosmithkline Ip No 2 Ltd |
低濃度抗體調配物
|
|
HUE048722T2
(hu)
|
2013-07-05 |
2020-08-28 |
Genmab As |
Humanizált vagy kiméra CD3 ellenanyagok
|
|
EP3299466B1
(en)
|
2013-07-18 |
2019-09-11 |
Vib Vzw |
Fusokines involving cytokines with strongly reduced receptor binding affinities
|
|
US9932409B2
(en)
|
2013-07-19 |
2018-04-03 |
Vib Vzw |
Targeted modified IL-1 family members
|
|
WO2015007520A1
(en)
|
2013-07-19 |
2015-01-22 |
Vib Vzw |
Targeting of cytokine antagonists
|
|
BR112016001114B1
(pt)
|
2013-07-19 |
2023-02-14 |
Vib Vzw |
Composição compreendendo uma proteína de fusão e uso da referida composição
|
|
CN105612175B
(zh)
*
|
2013-08-08 |
2023-05-09 |
赛腾制药 |
基于IL-15和IL-15Rαsushi结构域的调节因子
|
|
WO2015061752A1
(en)
*
|
2013-10-25 |
2015-04-30 |
Pharmacyclics, Inc. |
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
|
|
CN103536917B
(zh)
*
|
2013-10-30 |
2015-03-11 |
苏州丁孚靶点生物技术有限公司 |
干扰素在治疗肿瘤中的用途及相关的产品和方法
|
|
ES2716685T3
(es)
|
2014-01-24 |
2019-06-14 |
Dana Farber Cancer Inst Inc |
Moléculas de anticuerpo para PD-1 y usos de las mismas
|
|
UA119352C2
(uk)
|
2014-05-01 |
2019-06-10 |
Тева Фармасьютикалз Острейліа Пті Лтд |
Комбінація леналідоміду або помалідоміду і конструкції анти-cd38 антитіло-атенуйований інтерферон альфа-2b та спосіб лікування суб'єкта, який має cd38-експресуючу пухлину
|
|
WO2016002263A1
(ja)
|
2014-06-30 |
2016-01-07 |
ソニー株式会社 |
無線通信装置、無線通信方法及びプログラム
|
|
KR102762243B1
(ko)
*
|
2014-06-30 |
2025-02-05 |
알토 바이오사이언스 엘엘씨 |
Il-15-베이즈드 분자 및 이의 사용 방법
|
|
JP6544775B2
(ja)
|
2014-07-11 |
2019-07-17 |
株式会社ワコム |
位置指示器、位置検出装置、位置検出装置の入力制御方法および入力装置
|
|
KR20170052569A
(ko)
*
|
2014-07-18 |
2017-05-12 |
어드박시스, 인크. |
전립선암 치료용 pd-1 길항제 및 리스테리아 기반 백신의 병용
|
|
WO2016022630A1
(en)
|
2014-08-05 |
2016-02-11 |
Jiping Zha |
Anti-pd-l1 antibodies
|
|
EP2982693A1
(en)
|
2014-08-07 |
2016-02-10 |
Affimed Therapeutics AG |
CD3 binding domain
|
|
UY36351A
(es)
|
2014-10-14 |
2016-06-01 |
Novartis Ag |
Moléculas de anticuerpo que se unen a pd-l1 y usos de las mismas
|
|
CN115920007A
(zh)
|
2014-10-24 |
2023-04-07 |
阿斯利康(瑞典)有限公司 |
组合
|
|
EA037749B1
(ru)
|
2014-10-29 |
2021-05-18 |
Тева Фармасьютикалз Острэйлиа Пти Лтд |
ВАРИАНТЫ ИНТЕРФЕРОНА 2b
|
|
CN104403004B
(zh)
*
|
2014-11-24 |
2017-10-13 |
苏州丁孚靶点生物技术有限公司 |
抗体‑干扰素异二聚体的制备和用途
|
|
EP3371311B1
(en)
|
2015-11-06 |
2021-07-21 |
Orionis Biosciences BV |
Bi-functional chimeric proteins and uses thereof
|
|
US11661455B2
(en)
*
|
2016-02-05 |
2023-05-30 |
Orionis Biosciences BV |
Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety
|
|
DK3411398T3
(da)
|
2016-02-05 |
2024-06-24 |
Orionis Biosciences BV |
Målrettede terapeutiske midler og anvendelse heraf
|
|
EP3455245A2
(en)
*
|
2016-05-13 |
2019-03-20 |
Orionis Biosciences NV |
Therapeutic targeting of non-cellular structures
|